368 related articles for article (PubMed ID: 34650295)
1. [Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis].
Gao WB; Shi MJ; Zhang HY; Wu CB; Zhu JH
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):921-927. PubMed ID: 34650295
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
[TBL] [Abstract][Full Text] [Related]
3. Extreme hyperferritinemia: etiological spectrum and impact on prognosis.
Belfeki N; Strazzulla A; Picque M; Diamantis S
Reumatismo; 2020 Jan; 71(4):199-202. PubMed ID: 31995958
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of 192 adult hemophagocytic lymphohistiocytosis].
Huang W; Wang Y; Wang J; Zhang J; Wu L; Li S; Tang R; Zeng X; Chen J; Pei R; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):796-801. PubMed ID: 25246246
[TBL] [Abstract][Full Text] [Related]
5. Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis.
Denimal D; Ménégaut L; Rossi C; Duvillard L; Masson D
Biochem Med (Zagreb); 2016; 26(2):255-9. PubMed ID: 27346972
[TBL] [Abstract][Full Text] [Related]
6. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
[TBL] [Abstract][Full Text] [Related]
7. Familial Hemophagocytic Lymphohistiocytosis secondary to UNC13D mutation: a report of two cases.
Sadeghi P; Esslami GG; Rokni-Zadeh H; Changi-Ashtiani M; Mohsenipour R
BMC Pediatr; 2022 Nov; 22(1):667. PubMed ID: 36401200
[TBL] [Abstract][Full Text] [Related]
8. Hyperferritinemia in Critically Ill Patients.
Lachmann G; Knaak C; Vorderwülbecke G; La Rosée P; Balzer F; Schenk T; Schuster FS; Nyvlt P; Janka G; Brunkhorst FM; Keh D; Spies C
Crit Care Med; 2020 Apr; 48(4):459-465. PubMed ID: 32205591
[TBL] [Abstract][Full Text] [Related]
9. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis.
Yang SL; Xu XJ; Tang YM; Song H; Xu WQ; Zhao FY; Shen DY
Cytokine; 2016 Sep; 85():14-7. PubMed ID: 27269180
[TBL] [Abstract][Full Text] [Related]
10. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
Liu JH; Liu W; Li YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
[TBL] [Abstract][Full Text] [Related]
11. Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
Naymagon L; Tremblay D; Mascarenhas J
Eur J Haematol; 2020 Apr; 104(4):344-351. PubMed ID: 31991015
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
13. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis.
Valade S; Azoulay E; Galicier L; Boutboul D; Zafrani L; Stepanian A; Canet E; Lemiale V; Venot M; Veyradier A; Mariotte E
Medicine (Baltimore); 2015 Oct; 94(40):e1692. PubMed ID: 26448017
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
Hattori N; Sato M; Uesugi Y; Nakata A; Sasaki Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Uto Y; Matsui T; Yanagisawa K; Tahara S; Koeffler HP; Iezumi K; Nakamaki T
Int J Hematol; 2021 May; 113(5):693-702. PubMed ID: 33385294
[TBL] [Abstract][Full Text] [Related]
16. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic Effect of PE+CRRT Combined with Chemotherapy on Children with Severe EBV-HLH and Non-EBV-HLH].
Long YY; Huang CS; Huang P; Xu HB; Xie C; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):259-264. PubMed ID: 33554831
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
Eichenauer DA; La Rosée P
Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
[TBL] [Abstract][Full Text] [Related]
19. Comparison between clinical features and prognosis of malignancy- and non-malignancy-associated pediatric hemophagocytic lymphohistiocytosis.
Pan H; Huo Y; Sun L
BMC Pediatr; 2019 Nov; 19(1):468. PubMed ID: 31783813
[TBL] [Abstract][Full Text] [Related]
20. Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.
Wang HY; Yang CF; Chiou TJ; Yang SH; Gau JP; Yu YB; Chen PM; Hsu HC; Fung CP; Lin HY; Tzeng CH; Liu JH; Hsiao LT
Hematol Oncol; 2017 Dec; 35(4):835-844. PubMed ID: 27465587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]